Modulation of [99mTc]Tc-iPSMA preparation conditions reduces radiochemical species heterogeneity and supports a single-vial cold-kit formulation

Introduction Technetium-99 m labeling of hydrazinonicotinamide (HYNIC)-conjugated vectors requires transfer ligands and co-ligands that may generate multiple radiochemical species with slightly different physicochemical and biological properties. This study aimed to optimize the radiolabeling of the HYNIC-conjugated prostate-specific membrane antigen ligand iPSMA to reduce chromatographic heterogeneity while maintaining high radiochemical purity (RCP), and to translate the selected conditions into a single-vial cold-kit formulation. Methods Twenty radiolabeling conditions were evaluated through 3 replicates each by independently varying the co-ligand, transfer ligand, buffer, reducing agent, antioxidant, reaction time, and reaction temperature. Products were characterized by radio-HPLC and radio-TLC. The optimized conditions were subsequently applied to freeze-dried single-vial formulations containing one of five bulking agents. The effects of bulking-agent content, technetium-99 m activity, heating time, and pertechnetate eluate age were also investigated. Results The reference protocol yielded an RCP of 90.31 ± 0.83%, with the predominant radiolabeled species accounting for 76.97 ± 2.53% of the radiocomplexes. Among the investigated parameters, reaction-medium composition, particularly the buffer used, had the greatest influence on the chromatographic distribution of radiolabeled species. Using sodium acetate 0.2 M at pH 7 with EDDA and tricine increased RCP to 95.15 ± 0.29% and the proportion of the predominant radiolabeled species to 96.21 ± 0.23%. Reduced/hydrolyzed technetium remained below the radio-TLC detection limit. Mannitol provided the best cold-kit performance and was selected at 40 mg per vial. Under the present formulation conditions, satisfactory kit performance was obtained with ≤1.5 GBq of freshly eluted pertechnetate (<30 min), with 0.92 ± 0.11% residual pertechnetate, 91.47 ± 2.66% major radiolabeled species, and a RCP of 95.69 ± 1.28%. Conclusion Radio-HPLC-guided optimization markedly reduced radiochemical heterogeneity of [ 99m Tc]Tc-iPSMA while maintaining high RCP. The selected conditions could be translated into an all-in-one single-vial proof-of-concept formulation, although further analytical, pharmaceutical and biological development is required before clinical implementation.

Authors

Institutions

Publication Details

Journal
Frontiers in Nuclear Medicine
Published
2026-11-20
DOI
https://doi.org/10.3389/fnume.2026.1980206
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Modulation of [99mTc]Tc-iPSMA preparation conditions reduces radiochemical species heterogeneity and supports a single-vial cold-kit formulation

Léa Rubira, Cyril Fersing, Jade Torchio, Lina Stamboul et al.
1 links
Frontiers in Nuclear Medicine
Radiopharmaceutical Chemistry and Applications
article

Modulation of [99mTc]Tc-iPSMA preparation conditions reduces radiochemical species heterogeneity and supports a single-vial cold-kit formulation

Léa Rubira, Cyril Fersing, Jade Torchio, Lina Stamboul, Jeanne Chillard
article en

Abstract

Introduction Technetium-99 m labeling of hydrazinonicotinamide (HYNIC)-conjugated vectors requires transfer ligands and co-ligands that may generate multiple radiochemical species with slightly different physicochemical and biological properties. This study aimed to optimize the radiolabeling of the HYNIC-conjugated prostate-specific membrane antigen ligand iPSMA to reduce chromatographic heterogeneity while maintaining high radiochemical purity (RCP), and to translate the selected conditions into a single-vial cold-kit formulation. Methods Twenty radiolabeling conditions were evaluated through 3 replicates each by independently varying the co-ligand, transfer ligand, buffer, reducing agent, antioxidant, reaction time, and reaction temperature. Products were characterized by radio-HPLC and radio-TLC. The optimized conditions were subsequently applied to freeze-dried single-vial formulations containing one of five bulking agents. The effects of bulking-agent content, technetium-99 m activity, heating time, and pertechnetate eluate age were also investigated. Results The reference protocol yielded an RCP of 90.31 ± 0.83%, with the predominant radiolabeled species accounting for 76.97 ± 2.53% of the radiocomplexes. Among the investigated parameters, reaction-medium composition, particularly the buffer used, had the greatest influence on the chromatographic distribution of radiolabeled species. Using sodium acetate 0.2 M at pH 7 with EDDA and tricine increased RCP to 95.15 ± 0.29% and the proportion of the predominant radiolabeled species to 96.21 ± 0.23%. Reduced/hydrolyzed technetium remained below the radio-TLC detection limit. Mannitol provided the best cold-kit performance and was selected at 40 mg per vial. Under the present formulation conditions, satisfactory kit performance was obtained with ≤1.5 GBq of freshly eluted pertechnetate (<30 min), with 0.92 ± 0.11% residual pertechnetate, 91.47 ± 2.66% major radiolabeled species, and a RCP of 95.69 ± 1.28%. Conclusion Radio-HPLC-guided optimization markedly reduced radiochemical heterogeneity of [ 99m Tc]Tc-iPSMA while maintaining high RCP. The selected conditions could be translated into an all-in-one single-vial proof-of-concept formulation, although further analytical, pharmaceutical and biological development is required before clinical implementation.

Frontiers in Nuclear MedicineVol. 6
École Nationale Supérieure de Chimie de Montpellier (FR), Centre National de la Recherche Scientifique (FR), Institut des Biomolécules Max Mousseron (FR), Institut Regional du Cancer de Montpellier (FR)
Good health and well-being
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon